Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AZIYO BIOLOGICS, INC. (AZYO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net sales  10.313.112.712.412.611.510.911.5
            Net sales growth  -18.5%13.5%16.6%7.9%3.9%-10.8%-12.9%-2.5%
Cost of goods sold  9.36.77.77.37.77.27.57.8
    Gross profit  1.06.35.05.04.94.33.43.7
            Gross margin  9.5%48.5%39.4%40.8%38.8%37.2%31.2%32.1%
Sales and marketing  3.65.45.14.95.44.84.54.8
General and administrative  4.03.73.44.54.74.03.23.5
Research and development  1.21.82.12.02.62.33.42.3
FiberCel litigation costs, net  1.31.93.31.50.30.10.10.1
    Total operating expenses  10.112.713.812.813.111.211.210.7
    Loss from operations  -9.1-6.4-8.8-7.8-8.2-6.9-7.8-7.0
            Operating margin  -88.2%-49.2%-69.8%-62.9%-64.7%-60.2%-71.5%-60.7%
Interest expense  -1.5-1.5-1.6-1.3-1.2-1.2-1.3-1.3
    Loss before provision for income taxes  -10.6-8.0-5.4-9.9-9.4-8.1-9.1-8.3
Income tax expense  0.00.00.00.00.00.00.00.0
    Net loss  -10.6-8.0-5.4-9.9-9.4-8.1-9.1-8.3
   
Net loss per share - basic (in dollar per share)  ($0.65)($0.49)($0.36)($0.73)($0.69)($0.60)($0.84)($0.81)
Net loss per share - diluted (in dollar per share)  ($0.65)($0.49)($0.36)($0.73)($0.69)($0.60)($0.84)($0.81)
   
Weighted average common shares outstanding - basic  16.216.113.813.713.613.610.410.2
Weighted average common shares outstanding - diluted  16.216.113.813.713.613.610.410.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy